Investing Insights

Karen Anderson, director of healthcare equity research for Morningstar Research Services, discusses the forces shaping the landscape and where she sees opportunities for investors.  Key Takeaways:Why Healthcare Stocks Have Been Resilient During the Market DownturnHow Regulatory Changes Could Affect the Healthcare IndustryWhy Healthcare Stocks’ Valuations Look Attractive From a Bottom-Up ViewHow Have Healthcare Stocks’ Valuations Changed Historically?How Stock Valuations Differ Within the Healthcare Sector  How an Aging US Population Affects the Healthcare Sector  Will GLP-1 Drugs Continue to Grow?  Regulatory Risks for Healthcare Stocks  Healthcare Stocks Outlook  Are Healthcare Stocks a Buy?  Healthcare Stock Picks  How Amgen Is Using AI in Healthcare   Read about topics from this episode.  Healthcare: Sector Looks Undervalued with Pullback After US Election and Obesity DataNovo Nordisk: Next-Generation GLP-1/Amylin Drug Sees Leading Weight Loss in Small TrialHow GLP-1 Drugs Like Ozempic Are Boosting Biophar